Euglycemic hyperinsulinemia increases blood pressure in pregnant rats independent of placental antiangiogenic and inflammatory factors

American Journal of Hypertension

Volumn 26, Issue 12, 2013, Pages 1445-1451

  Palei, Ana C ^a   Spradley, Frank T ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hyperinsulinemia; Hypertension; Preeclampsia; Pregnancy

Indexed keywords

CHOLESTEROL; FATTY ACID; GLUCOSE; INSULIN; LEPTIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CHRONIC DISEASE; FEMALE; GESTATION PERIOD; HEART RATE; HYPERINSULINEMIA; HYPERTENSION; INDWELLING CATHETER; LITTER SIZE; MEAN ARTERIAL PRESSURE; NONHUMAN; OSMOTIC MINIPUMP; PLACENTA; PLACENTA WEIGHT; PRIORITY JOURNAL; RAT;

EID: 84890455196     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt137     Document Type: Article

References (46)

1. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003; 41:437-445.
2. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-799.
3. Granger JP, Alexander BT, Llinas MT, Bennett WA, Khalil RA. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 2002; 9:147-160.
4. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46:1243-1249.
5. Broughton Pipkin F. Risk factors for preeclampsia. N Engl J Med 2001; 344:925-926.
6. Trogstad L, Magnus P, Stoltenberg C. Pre-eclampsia: risk factors and causal models. Best Pract Res Clin Obstet Gynaecol 2011; 25:329-342.
7. Catalano PM, Tyzbir ED, Wolfe RR, Roman NM, Amini SB, Sims EA. Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women. Am J Obstet Gynecol 1992; 167:913-919.
8. Agardh CD, Aberg A, Norden NE. Glucose levels and insulin secretion during a 75 g glucose challenge test in normal pregnancy. J Intern Med 1996; 240:303-309.
9. Rossi G, Sherwin RS, Penzias AS, Lapaczewski P, Jacob RJ, Shulman GI, Diamond MP. Temporal changes in insulin resistance and secretion in 24-h-fasted conscious pregnant rats. Am J Physiol 1993; 265:E845-E851.
10. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab 2003; 88:2393-2398.
11. Roberts JM, Gammill H. Insulin resistance in preeclampsia. Hypertension 2006; 47:341-342.
12. Potenza MA, Addabbo F, Montagnani M. Vascular actions of insulin with implications for endothelial dysfunction. Am J Physiol Endocrinol Metab 2009; 297:E568-E577.
13. Mackesy DZ, Goalstone ML. Insulin augments tumor necrosis factoralpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells. J Inflamm (Lond) 2011; 8:34.
14. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, Van Obberghen E. Insulin and insulin-like growth factor-i induce vascular endothelial growth factor mrna expression via different signaling pathways. J Biol Chem 2000; 275:21695-21702.
15. Podjarny E, Bernheim J, Katz B, Green J, Mekler J, Bursztyn M. Chronic exogenous hyperinsulinemia in pregnancy: a rat model of pregnancyinduced hypertension. J Am Soc of Nephrol 1998; 9:9-13.
16. Podjarny E, Bursztyn M, Rashed G, Benchetrit S, Katz B, Green J, Karmeli F, Peleg E, Bernheim J. Chronic exogenous hyperinsulinaemiainduced hypertension in pregnant rats: effect of chronic treatment with l-Arginine. Clin Sci (Lond) 2001; 100:667-671.
17. Hamasaki T, Yasuhi I, Hirai M, Masuzaki H, Ishimaru T. Hyperinsulinemia increases the risk of gestational hypertension. Int J Gynaecol Obstet 1996; 55:141-145.
18. Solomon CG, Carroll JS, Okamura K, Graves SW, Seely EW. Higher cholesterol and insulin levels in pregnancy are associated with increased risk for pregnancy-induced hypertension. Am J Hypertens 1999; 12:276-282.
19. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991; 260:R764-R768.
20. Brands MW, Lee WF, Keen HL, Alonso-Galicia M, Zappe DH, Hall JE. Cardiac output and renal function during insulin hypertension in sprague-dawley rats. Am J Physiol 1996; 271:R276-R281.
21. Negrato CA, Jovanovic L, Tambascia MA, Geloneze B, Dias A, Calderon Ide M, Rudge MV. Association between insulin resistance, glucose intolerance, and hypertension in pregnancy. Metab Syndr Relat Disord 2009; 7:53-59.
22. Parretti E, Lapolla A, Dalfra M, Pacini G, Mari A, Cioni R, Marzari C, Scarselli G, Mello G. Preeclampsia in lean normotensive normotolerant pregnant women can be predicted by simple insulin sensitivity indexes. Hypertension 2006; 47:449-453.
23. Laivuori H, Tikkanen MJ, Ylikorkala O. Hyperinsulinemia 17 years after preeclamptic first pregnancy. J Clin Endocrinol Metab 1996; 81:2908-2911.
24. Girouard J, Giguere Y, Moutquin JM, Forest JC. Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance. Hypertension 2007; 49:1056-1062.
25. Fuh MM, Yin CS, Pei D, Sheu WH, Jeng CY, Chen YI, Reaven GM. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens 1995; 8:768-771.
26. Bursztyn M, Podjarny E, Dahan R, Raz I, Bernheim J. Insulin-induced hypertension, l-Arginine, and endothelial nitric oxide synthase in pregnant rats. Hypertens Pregnancy 2003; 22:267-274.
27. Khamaisi M, Skarzinski G, Mekler J, Zreik F, Damouni R, Ariel I, Bursztyn M. Hyperinsulinemia increases placenta endothelin-converting enzyme-1 expression in trophoblasts. Am J Hypertens 2012; 25:109-114.
28. Skarzinski G, Khamaisi M, Bursztyn M, Mekler J, Lan D, Evdokimov P, Ariel I. Intrauterine growth restriction and shallower implantation site in rats with maternal hyperinsulinemia are associated with altered nos expression. Placenta 2009; 30:898-906.
29. Fagius J. Sympathetic nerve activity in metabolic control-some basic concepts. Acta Physiol Scand 2003; 177:337-343.
30. Brands MW, Harrison DL, Keen HL, Gardner A, Shek EW, Hall JE. Insulin-induced hypertension in rats depends on an intact renin-Angiotensin system. Hypertension 1997; 29:1014-1019.
31. Keen HL, Brands MW, Alonso-Galicia M, Hall JE. Chronic adrenergic receptor blockade does not prevent hyperinsulinemia-induced hypertension in rats. Am J Hypertens 1996; 9:1192-1199.
32. Keen HL, Brands MW, Smith MJ Jr, Hall JE. Maintenance of baseline angiotensin II potentiates insulin hypertension in rats. Hypertension 1998; 31:637-642.
33. Keen HL, Brands MW, Smith MJ Jr, Shek EW, Hall JE. Inhibition of thromboxane synthesis attenuates insulin hypertension in rats. Am J Hypertens 1997; 10:1125-1131.
34. Maric-Bilkan C, Manigrasso MB. Sex differences in hypertension: contribution of the renin-Angiotensin system. Gend Med 2012; 9:287-291.
35. Wenner MM, Stachenfeld NS. Blood pressure and water regulation: understanding sex hormone effects within and between men and women. J Physiol 2012; 590:5949-5961.
36. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009; 1:60-75.
37. Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci (Lond) 2002; 102:151-166.
38. Scherrer U, Sartori C. Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96:4104-4113.
39. Gilbert J, Dukes M, LaMarca B, Cockrell K, Babcock S, Granger J. Effects of reduced uterine perfusion pressure on blood pressure and metabolic factors in pregnant rats. Am J Hypertens 2007; 20:686-691.
40. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston L. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187:127-136.
41. Lorentzen B, Endresen MJ, Clausen T, Henriksen T. Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 1994; 13:103-109.
42. Ciampelli M, Lanzone A, Caruso A. Insulin in obstetrics: a main parameter in the management of pregnancy. Hum Reprod Update 1998; 4:904-914.
43. Bernstein IM, Goran MI, Copeland KC. Maternal insulin sensitivity and cord blood peptides: relationships to neonatal size at birth. Obstet Gynecol 1997; 90:780-783.
44. Catalano PM, Drago NM, Amini SB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. Am J Obstet Gynecol 1995; 172:1464-1470.
45. Caruso A, Paradisi G, Ferrazzani S, Lucchese A, Moretti S, Fulghesu AM. Effect of maternal carbohydrate metabolism on fetal growth. Obstet Gynecol 1998; 92:8-12.
46. Ojha S, Saroha V, Symonds ME, Budge H. Excess nutrient supply in early life and its later metabolic consequences. Clin Exp Pharmacol Physiol 2013; e-pub ahead of print 26 January 2013.